As investments in life science companies have dipped over the past few years, some investors have scaled back investments or walked away from the sector all together. But based on a tally by investment research firm PitchBook in its 2013 Venture Capital Healthcare Report, several firms have made 10 or more investments in pharmaceutical, medical device or health IT companies in the last year and a half.
Here is PitchBook’s list of the most active life science Vcs between January 2012 and May 2013.
Early stage:
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
- Third Rock Ventures
- Versant Ventures
- Novartis Venture Funds
- SV Life Science Advisers
- Connecticut Innovations
Late stage:
- OrbiMed Advisors
- New Enterprise Associates
- Versant Ventures
- Domain Associates
- New Leaf Venture Partners
- KPCB
- Aisling Capital
- SV Life Science Advisers
- MPM Capital
To find more firms funding life science and health IT startups, head over to MedCity’s money map.
